• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, May 10, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

IADR/AADR divests sugar-sweetened beverage companies from investment portfolio

Bioengineer by Bioengineer
January 15, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Alexandria, VA, USA – The International Association for Dental Research (IADR) and the American Association for Dental Research (AADR) announce the divestment of sugar-sweetened beverage companies from their investment portfolios. While IADR and AADR did not have direct investments in such companies, they’ve changed to investment managers who will screen out any holdings in the sector. The IADR and AADR already exclude any investments in tobacco companies.

The scientific evidence is clear that sugars are the most important dietary factor in the development of dental caries. Sugar-sweetened beverages are a major source of dietary sugars, lack nutritional value, and contribute not only to dental caries, but to unhealthy weight gain, obesity, and increased risk for diabetes and cardiovascular disease. Investing in companies that manufacture or distribute sugar-sweetened beverages or funds that have such holdings is inconsistent with the Missions of IADR and AADR which are to advance research and increase knowledge for the improvement of oral health worldwide.

“There is robust research that identifies free sugars as a major cause of dental caries and sugar-sweetened beverages are a major source of free sugars and are linked to a number of non-communicable diseases,” said AADR President Maria Emanuel Ryan. IADR President Rena D’Souza continued, “the initiative to remove all investments in sugar-sweetened beverage companies, matches IADR/AADR’s previous divestment of tobacco stocks and more clearly embodies our investment philosophy and health-based values.”

The IADR and AADR call on other health-related professional associations with investment portfolios to adopt similar policies regarding sugar-sweetened beverage companies.

###

For press inquiries or more information, please contact Elise Bender [email protected].

About the International Association for Dental Research

The International Association for Dental Research (IADR) is a nonprofit organization with over 11,400 individual members worldwide, dedicated to: (1) advancing research and increasing knowledge for the improvement of oral health worldwide, (2) supporting and representing the oral health research community, and (3) facilitating the communication and application of research findings. To learn more, visit http://www.iadr.org. The American Association for Dental Research (AADR) is the largest Division of IADR with 3,300 members in the United States. To learn more, visit http://www.iadr.org/aadr.

Media Contact
Elise Bender
[email protected]
http://www.iadr.org/IADR/About-Us/News/ArtMID/132983/ArticleID/596/IADRAADR-Divests-Sugar-sweetened-Beverage-Companies-from-Investment-Portfolio

Tags: Dentistry/Periodontal DiseaseDiet/Body WeightMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Evaluating Digoxin Use in Patients with Symptomatic Rheumatic Heart Disease

May 10, 2026

Evaluating the Effectiveness and Safety of Digitalis Glycosides in Treating Heart Failure

May 10, 2026

Urdu Fall Risk Questionnaire Adapted for Elderly

May 10, 2026

Key Pharmacological Markers for HIV Prevention in MSM

May 10, 2026
Please login to join discussion

POPULAR NEWS

  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    840 shares
    Share 336 Tweet 210
  • New Study Reveals Plants Can Detect the Sound of Rain

    727 shares
    Share 290 Tweet 181
  • Scientists Investigate Possible Connection Between COVID-19 and Increased Lung Cancer Risk

    68 shares
    Share 27 Tweet 17
  • Salmonella Haem Blocks Macrophages, Boosts Infection

    61 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Evaluating Digoxin Use in Patients with Symptomatic Rheumatic Heart Disease

Evaluating the Effectiveness and Safety of Digitalis Glycosides in Treating Heart Failure

Urdu Fall Risk Questionnaire Adapted for Elderly

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.